Bio-Reference Labs (BRLI) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts BRLI Hot Sheet
Price: $4.70 --0%
Financial Fact:
GROSS PROFIT ON REVENUES: 98.98M
Today's EPS Names:
ZVOI, SYRS, ATRA, More
Financial Fact:
GROSS PROFIT ON REVENUES: 98.98M
Today's EPS Names:
ZVOI, SYRS, ATRA, More
Join SI Premium – FREE
Bio-Reference Labs (NASDAQ: BRLI) reported Q3 EPS of $0.55, $0.02 better than the analyst estimate of $0.53. Revenue for the quarter came in at $222.05 thousand versus the consensus estimate of $210.44 thousand.
For earnings history and earnings-related data on Bio-Reference Labs (BRLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BrightSpring Health Services, Inc. (BTSG) Tops Q3 EPS by 34c ; Offers Guidance
- Firstsource Solutions Ltd (FSOL:IN) PT Raised to INR250 at Kotak
- Magna International (MGA) Tops Q3 EPS by 25c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
